Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.
about
Functional redundancy of MyD88-dependent signaling pathways in a murine model of histidyl-transfer RNA synthetase-induced myositis.Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosisAutophagy, inflammation and innate immunity in inflammatory myopathiesType I interferon pathway in adult and juvenile dermatomyositis.Resistin in idiopathic inflammatory myopathies.TLR2 was overexpressed independent of IL-6 in patients with valvular atrial fibrillation.Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weaknessThe role of resistin in inflammatory myopathies.Role of Jo-1 in the Immunopathogenesis of the Anti-synthetase Syndrome.Immunological biomarkers in dermatomyositis.Calprotectin in rheumatic diseases.Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with DermatomyositisAltered RIG-I/DDX58-mediated innate immunity in dermatomyositis.Toll-Like Receptor 4-Myeloid Differentiation Primary Response Gene 88 Pathway Is Involved in the Inflammatory Development of Polymyositis by Mediating Interferon-γ and Interleukin-17A in Humans and Experimental Autoimmune Myositis Mouse Model.Association between toll-like receptor 6 expression and auxiliary T cells in the peripheral blood of pediatric patients with allergic purpura.Toll-like receptors promote inflammation in idiopathic inflammatory myopathies.Development of psoriasis with relapse of dermatomyositis-associated interstitial lung disease.Human β-defensin-3 correlates with muscle fibre degeneration in idiopathic inflammatory myopathies.Dysregulation of the type I interferon system in adult-onset clinically amyopathic dermatomyositis has a potential contribution to the development of interstitial lung disease.
P2860
Q35095086-77F7F742-A599-48B3-AB29-21B95EEDD499Q35163334-016BBC22-F932-456F-9097-5A9DEA3350CFQ35388047-DD26B410-B1B0-4FEF-AD4F-CAE0FCC2570EQ35907790-F1ACBC37-D9A6-4AD2-88A0-BAA7CA40BF03Q36245955-066DA9C3-0505-43ED-B088-E0CBED45848BQ36683218-42EB7C73-8DB6-42B6-A4F1-4093F21C286BQ36926351-F401FF5C-484E-473A-8E55-67107FCB2236Q38099557-7FB1618C-602E-486B-B32A-7ABAB9297AB4Q38554195-B5EA64CA-7FF2-4DA7-9B5D-026B0CBD3520Q38592676-D372452F-445B-4243-A79F-E8A8DE08A222Q39022858-336F99D4-E2C6-449C-8B60-8871AC25764CQ41487374-42A06198-BDA2-4D80-B17C-55C67EF8EFA2Q42233198-32570829-B43C-4789-8082-D2E6D48D94F8Q42292003-5053437A-0050-440E-BE61-33E763508842Q43244117-B0796BFD-4FE5-4296-B996-2D075368319FQ45207411-3F5611F8-73EE-44B3-95F3-4F51E2A68C65Q48292416-8C3AFAFC-A832-4345-B9E0-69F025971DC3Q51051585-8784D10A-F66A-4ED6-B7EC-BE9B8B417D04Q51317487-147E36CF-C751-4A2D-87F7-9A63015037F5
P2860
Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.
@ast
Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.
@en
type
label
Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.
@ast
Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.
@en
prefLabel
Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.
@ast
Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.
@en
P2093
P2860
P921
P1476
Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.
@en
P2093
Dae-Sung Kim
Geun-Tae Kim
Ho-Youn Kim
Hye-Jwa Oh
Jun-Hee Lee
Jung-Hee Kim
Seung-Hoon Baek
Sun-Hee Lee
Sung-Il Kim
P2860
P304
P356
10.1007/S10067-009-1316-7
P577
2009-12-02T00:00:00Z